Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease

BACKGROUND: Existing therapies for recurrent or refractory histiocytoses, including Langerhans cell histiocytosis (LCH), juvenile xanthogranuloma (JXG), and Rosai-Dorfman disease (RDD), have limited effectiveness. We report our experience with using clofarabine as therapy in children with recurrent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Simko, Stephen J., Tran, Huy D., Jones, Jeremy, Bilgi, Mrinalini, Beaupin, Lynda Kwon, Coulter, Don, Garrington, Timothy, McCavit, Timothy L., Moore, Colin, Rivera-Ortegón, Francisco, Shaffer, Linda, Stork, Linda, Turcotte, Lucie, Welsh, Esperanza C., Hicks, M. John, McClain, Kenneth L., Allen, Carl E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474604/
https://ncbi.nlm.nih.gov/pubmed/24106153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24772
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados